ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Denali Therapeutics Inc

Denali Therapeutics Inc (DNLI)

21.25
0.00
(0.00%)
Closed January 09 4:00PM
0.00
0.00
(0.00%)

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 52.48M3.56M10.28M35.14M0000
Operating Income -61.42M-107.49M-105.34M-120.82M-132.57M-132.25M-116.59M-123.19M
Pre Tax Income -58.77M-103.3M-98.68M-109.78M-119.44M-101.8M-99.03M-107.19M
Net Income -58.79M-103.3M-98.68M-109.78M-119.47M-101.8M-99.03M-107.19M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -61.42M-107.49M-105.34M-120.82M-132.57M-117.72M-116.59M-123.19M
EBITDA -59.34M-105.35M-101.25M-110.77M-130.4M-130.09M-114.65M-121.35M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00129.16M26.68M335.66M48.66M108.46M330.53M
Operating Income -87.43M-90.14M-46.37M-213.18M62.72M-295.75M-340.74M-196.7M
Pre Tax Income -86.65M-88.19M-36.64M-197.97M71.96M-291.16M-325.97M-145.19M
Net Income -86.65M-88.19M-36.64M-197.61M71.14M-290.58M-325.99M-145.22M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -10.079-1.008-0.387-2.0540.59-2.376-2.398-1.051
EBIT -87.43M-90.14M-46.37M-213.18M62.72M-295.75M-340.74M-196.7M
EBITDA -85.93M-87.06M-38.96M-205.19M71.25M-287.15M-330.36M-179.97M